Top

Indian Journal of Surgical Oncology

Published in:

01-06-2017 | Letter to the Editor

Discordance in Immunohistochemical Status of Breast Cancer Post Neoadjuvant Chemotherapy

Authors: Sanjit Kumar Agrawal, Sanjoy Chatterjee, Indu Arun, Rosina Ahmed

Published in: Indian Journal of Surgical Oncology | Issue 2/2017

Excerpt

Dear Sir, …

Anand AS, Velayudhan ST (2016) Discordance of estrogen & progesterone receptors after neoadjuvant chemotherapy in breast cancer—an Indian study. Indian journal of surgical oncology 7(3):316–319CrossRefPubMed

Chatterjee S, Saha A, Arun I, Nayak SS, Sinha S, Agrawal S et al (2015) Correlation of clinicopathological outcomes with changes in IHC4 status after NACT in locally advanced breast cancers: do pre-NACT ER/PR status act as better prognosticators? Breast cancer 7:381–388PubMedPubMedCentral

Agrawal S, Banswal L, Saha A, Arun I, Datta S S, Chatterjee S, Ahmed R. Progesterone receptors, pathological complete response and early outcome for locally advanced breast cancer—a single centre study. (PPLB – 01). Indian Journal of Surgical Oncology, Springer, DOI 10.1007/s13193-016-0523

Van de Ven S, Smit VTHBM, Dekker TJA, Nortier JWR, Kroep JR. Discordances in ER, PR and HER2 receptors after neoadjuvant chemotherapy in breast cancer. Cancer Treatment Reviews; 37(6): 422–30

Napa Parinyanitikul, Xiudong Lei, Mariana Chavez-Mac Gregor, Elizabeth Ann Mittendorf, Jennifer Keating Litton, Wendy A. Woodward, Hong Zhang, Gabriel N. Hortobagyi, Ana M. Gonzalez-Angulo. Receptor status changes from primary to residual breast cancer after neoadjuvant chemotherapy (NCT) and analysis of survival outcomes. J Clin Oncol 31, 2013 (suppl 26; abstr 48)

Cassidy JW, Caldas C, Bruna A (2015) Maintaining tumour heterogeneity in patient-derived tumour xenografts. Cancer Res 75(15):2963–2968. doi:10.1158/0008-5472.CAN-15-0727 CrossRefPubMedPubMedCentral

Sun X, Intra-tumor YQ (2015) Heterogeneity of cancer cells and its implications for cancer treatment. Acta Pharmacol Sin 36(10):1219–1227. doi:10.1038/aps.2015.92 CrossRefPubMedPubMedCentral

Jin G, Han Y, Liu C et al (2015) Evaluation of biomarker changes after administration of various neoadjuvant chemotherapies in breast cancer. International journal of clinical and experimental pathology 8(1):914–921PubMedPubMedCentral

Title: Discordance in Immunohistochemical Status of Breast Cancer Post Neoadjuvant Chemotherapy
Authors: Sanjit Kumar Agrawal
Sanjoy Chatterjee
Indu Arun
Rosina Ahmed
Publication date: 01-06-2017
Publisher: Springer India
Published in: Indian Journal of Surgical Oncology / Issue 2/2017
Print ISSN: 0975-7651
Electronic ISSN: 0976-6952
DOI: https://doi.org/10.1007/s13193-016-0606-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Discordance in Immunohistochemical Status of Breast Cancer Post Neoadjuvant Chemotherapy

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 2/2017

Screening and Detection of Prostate Cancer—Review of Literature and Current Perspective

Radical Prostatectomy for Locally Advanced Prostate Cancers—Review of Literature

Unusual Histology in Hodgkin’s Lymphoma: Report of an Interesting Case

Angiomyofibroblastoma of the Foot: a Rare Soft Tissue Tumor at Unusual Site

Dural Metastasis from a Rare Renal Neoplasm Masquerading Meningioma

Prognostic Factors in Indian Patients Operated for Soft Tissue Sarcomas—a Retrospective Cross-sectional Analysis